mifepristone has been researched along with meteneprost in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bygdeman, M; Gottlieb, C | 1 |
| Bygdeman, M; Gottlieb, C; Green, K; Swahn, ML | 1 |
| Dubois, C; Goepp, A; Maria, B; Stampf, F | 1 |
| Maria, B; Stampf, F | 1 |
| Dubois, C; Ulmann, A | 1 |
| Agarwal, N; Buckshee, K; Sehgal, R; Takkar, D | 1 |
4 trial(s) available for mifepristone and meteneprost
| Article | Year |
|---|---|
Clinical trials with RU 486 (mifepristone): an update.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Clinical Trials as Topic; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1989 |
A multicentre clinical trial with RU 486 followed by 9-methylene-PGE2 vaginal gel for termination of early pregnancy: a dose-finding study. Indian Council of Medical Research Task Force on Hormonal Contraception.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Induced; Adult; Female; Gels; Humans; Mifepristone; Pregnancy; Vagina | 1994 |
Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 1999 |
A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE(2) gel (meteneprost) or 600 microg oral PGE(1) (misoprostol) for termination of early pregnancy within 28 days of missed
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Therapeutic; Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Menstrual Cycle; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy | 2000 |
4 other study(ies) available for mifepristone and meteneprost
| Article | Year |
|---|---|
The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1991 |
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Induced; Administration, Oral; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progestins; Prostaglandins E, Synthetic; Uterine Contraction | 1990 |
Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Female; France; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic | 1990 |
Termination of early pregnancy using mifepristone in combination with prostaglandin analogs.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1989 |